New priority pathway

THE, Therapeutic Goods Administration has confirmed the implementation of a Priority Review pathway for the registration of novel prescription medicines for Australian patients, with a target timeframe for assessment of 150 days - up to 30 days shorter than standard registration processes.

Details now at www.tga.gov.au.